Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study

PURPOSE: We evaluated the dose-responsiveness, efficacy, and safety of low-dose triple antihypertensive combination therapies in patients with mild-to-moderate hypertension. PATIENTS AND METHODS: After a 1 to 2-week placebo run-in period, 248 patients were randomized to the half-dose triple combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Soon Jun, Sung, Ki-Chul, Lim, Sang-Wook, Kim, Seok-Yeon, Kim, Weon, Shin, Jinho, Park, Sungha, Kim, Hae-Young, Rhee, Moo-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781016/
https://www.ncbi.nlm.nih.gov/pubmed/33408462
http://dx.doi.org/10.2147/DDDT.S286586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781016/
https://www.ncbi.nlm.nih.gov/pubmed/33408462
http://dx.doi.org/10.2147/DDDT.S286586

Ejemplares similares